Login

Alan Beasley, CEO, Hydroponics Company Ltd 00:00:00

Share On Facebook Share On Twitter

OnMarket IPO: The Hydroponics Company (ASX:THC) interview with Alan Beasley & Andrew Beehag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Interview with Johan: Petra Diamonds' Strategic Developments and Market Outlook
00:10:00
Lumen Technologies announced a CEO transition, signaling significant developments in the telecom industry.
00:10:00
Uncertainty Surrounds Yen Carry Trade Unwind and Financial Conditions
00:10:00
From Medical Aspirations to Global Leadership at KPMG | William B. Thomas, CEO , KPMG.
00:10:00
Are Your Emotions or Finances in Control? Let's Talk.
00:10:00
Innovative Digital Transformation at Boustead Projects | Wong Yu Wei - Executive Deputy Chairman of Boustead Projects Limited
00:10:00
Kancera CEO Thomas Olin Discusses Kand567 Phase 2 Studies for COVID-19 and Acute Myocardial Infarction | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Strength and Rewards: Unveiling the Success of GMS in the Industry | Josh Helbig, CEO, GMS Mine Repair & Maintenance (TS)
00:10:00
Highlights from Itaú Unibanco's Third Quarter : Growth, Profitability, and Innovations | Milton Maluhy Filho , Vice - President , Itaú Unibanco.
00:10:00
focused on investing in technology startups operating in highly-regulated markets|Bradley Tusk, Managing Partner,Tusk Venture Partners
00:10:00
Newfoundland and Labrador's Mining Industry: Resilience and Growth Amid Global Challenges
00:10:00
Enhancing Financial Planning with Technology and Personalization

© 2017 - Neuhu+